A set of agreements to make COVID-19 antigen rapid tests available to low- and middle-income countries was announced on 28 September by the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration initiative launched earlier this year by groups including the World Health Organization (WHO).
The ACT Accelerator will initially make available 120 million tests under its remit to foster the development of COVID-19 vaccines, medicines and diagnostics and to make sure they reach those...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?